monoclon
antibodi
quebec
isol
bovin
coronaviru
produc
character
monoclon
antibodi
glycoprotein
found
effici
neutral
viru
vitro
none
monoclon
antibodi
direct
el
glycoprotein
neutral
viru
infect
neutral
monoclon
antibodi
glycoprotein
found
immunoprecipit
gpl
gpl
intracellular
precursor
protein
neutral
monoclon
antibodi
glycoprotein
immunoprecipit
show
differenti
reactiv
precursor
protein
gpl
monoclon
antibodi
also
show
differenti
reactiv
appar
degrad
product
neutral
monoclon
antibodi
bound
two
distinct
nonoverlappig
antigen
domain
defin
competit
bind
assay
neutral
monoclon
antibodi
glycoprotein
also
bound
two
distinct
antigen
site
defin
competit
bind
assay
plu
third
site
overlap
region
result
indic
one
domain
glycoprotein
could
subdivid
two
epitop
thu
four
epitop
could
defin
monoclon
antibodi
c
academ
press
inc
bovin
coronaviru
bcv
enter
viru
compos
four
structur
protein
three
protein
analog
mous
hepat
viru
mhv
strain
transmembran
protein
molecular
weight
mw
larg
peplomer
protein
coronavirus
exist
uncleav
cleav
form
approxim
respect
n
nucleocapsid
protein
trimer
sturman
holm
sturman
et
al
storz
et
al
king
brian
hogu
et
al
robbin
et
deregt
et
al
press
fourth
protein
bcv
disulfidelink
dimer
molecular
weight
approxim
reduc
two
appar
ident
subunit
king
brian
deregt
et
al
press
protein
identifi
bcv
hemagglutinin
appear
sturman
holm
hogu
et
king
al
bcv
quebec
isol
intracellular
precursor
protein
recent
identifi
us
deregt
et
press
precursor
protein
bcv
protein
gpl
glycoprotein
mw
protein
appar
glycosyl
yield
r
portion
work
present
third
intern
coronaviru
symposium
asilomar
request
reprint
address
subsequ
proteolyt
cleavag
yield
two
presumpt
comigr
speci
believ
result
cleavag
precursor
protein
bcv
glycoprotein
monom
disulfidelink
dimer
primari
precursor
found
appar
undergo
rapid
dimer
produc
gpl
glycosyl
gp
report
monoclon
antibodi
bcv
character
specif
abil
neutral
viru
infect
monoclon
antibodi
bcv
glycoprotein
found
effici
neutral
viru
infect
vitro
absenc
complement
also
report
neutral
epitop
protein
topograph
map
character
quebec
isol
bcv
obtain
dea
depart
patholog
microbiolog
faculti
veterinari
medicin
univers
montreal
st
hyacinth
quebec
use
studi
dea
et
al
viru
propag
madindarbi
bovin
kidney
mdbk
cell
purifi
describ
previous
deregt
et
al
press
bcv
infect
assay
mdbk
cell
plaqu
allow
develop
agaros
previous
describ
deregt
et
al
press
quantifi
virusneutr
abil
monoclon
antibodi
pfu
viru
mem
incub
equal
volum
variou
dilut
heatinactiv
min
mous
ascit
fluid
hr
virusascit
fluid
mixtur
allow
adsorb
confluent
mdbk
monolay
hr
control
includ
ascit
fluid
contain
monoclon
antibodi
bovin
herp
neutral
endpoint
titer
express
reciproc
highest
dilut
monoclon
antibodi
gave
reduct
plaqu
number
product
conjug
monoclon
antibodi
balbc
mice
immun
either
purifi
whole
viru
sdsdenatur
viru
prepar
cianfriglia
et
product
monoclon
antibodi
describ
elsewher
deregt
et
al
press
monoclon
isotyp
determin
enzym
immunoassay
hybridoma
supernat
hyclon
laboratori
logan
ut
total
igg
concentr
ascit
fluid
determin
radial
immunodiffus
icn
immunobiolog
lisl
il
monoclon
antibodi
conjug
horseradish
peroxidas
hrp
method
nakan
kawaoi
modifi
van
den
hurk
kurstak
enzymelink
immunosorb
assay
elisa
antibodybind
curv
titrat
ascit
fluid
perform
nineti
microlit
purifi
bcv
coat
buffer
ph
appli
well
polystyren
microtit
plate
immulon
dyntech
laboratori
inc
fisher
scientif
edmonton
alberta
incub
overnight
plate
wash
five
time
wash
buffer
pb
ph
contain
tween
pbst
block
buffer
pbst
contain
heatinactiv
hors
serum
gibco
ad
well
incub
hr
room
temperatur
block
unreact
site
plate
wash
pbst
monoclon
antibodi
serial
dilut
pbst
contain
hors
serum
pbst
ad
incub
hr
room
temperatur
wash
plate
remov
unbound
antibodi
dilut
hrpconjug
goat
antimous
monoclon
antibodi
bovin
coronaviru
igg
igm
boehringermannheim
dorval
quebec
dilut
pbst
ad
incub
hr
room
temperatur
final
wash
plate
pest
substrat
solut
contain
mgml
recrystal
acid
hydrogen
peroxid
phosphat
buffer
ph
ad
well
enzym
reaction
termin
min
incub
room
temperatur
addit
sodium
azid
saunder
et
al
optic
densiti
nm
determin
immedi
addit
sodium
azid
use
microelisa
reader
dynatech
endpoint
titer
determin
point
antibodybind
curv
cross
averag
absorb
attribut
nonspecif
bind
conjug
antibodi
plate
experi
use
satur
amount
hrpconjug
goat
antimous
igg
dilut
low
use
incub
hr
enzym
reaction
substrat
termin
min
substrat
becam
limit
competit
bind
assay
procedur
first
describ
except
hrpconjug
monoclon
antibodi
concentr
equival
approxim
satur
level
differ
hrpconjug
monoclon
antibodi
pbst
use
place
hrpconjug
goat
antimous
igg
igm
competit
curv
calcul
describ
kimurakurado
yasui
use
formula
n
l
od
absenc
compet
antibodi
b
od
presenc
homolog
antibodi
dilut
n
od
presenc
competitor
dilut
thu
definit
selfcompetit
low
dilut
homolog
unlabel
antibodi
equal
measur
competit
heterolog
unlabel
antibodi
rel
measur
competit
plateau
regard
strong
greater
signific
neg
less
actual
selfcompetit
calcul
use
formula
b
b
instanc
correct
nonspecif
bind
measur
bind
antimouseconjug
antibodi
well
incub
without
unlabel
competitor
antibodi
confluent
monolay
mdbk
cell
wash
mem
viru
multipl
infect
pfucel
adsorb
hr
adsorpt
inoculum
remov
replac
mem
fb
medium
remov
replac
methionin
methioninedefici
medium
hr
postadsorpt
hr
postadsorpt
cell
wash
harvest
icecold
pb
pellet
prepar
radioimmunoprecipit
electrophoresi
pulsechas
experi
cell
starv
methionin
hr
label
ml
sjmethionin
methioninedefici
medium
begin
hr
differ
experi
puls
cell
wash
mem
mem
contain
time
normal
concentr
methionin
incub
medium
min
harvest
procedur
use
radioimmunoprecipit
essenti
describ
previous
deregt
et
al
press
purifi
bcv
solubl
variou
sampl
buffer
see
page
protein
fraction
polyacrylamid
gel
protein
transfer
nitrocellulos
paper
biorad
byelectroblot
v
constant
hr
trisglycin
methanol
buffer
mm
trishydrochlorid
ph
mm
glycin
methanol
transfer
blot
block
skim
milk
powder
smp
pb
overnight
blot
cut
strip
monoclon
antibodi
dilut
hybridoma
supernat
ascit
fluid
dilut
rabbit
antibcv
polyclon
serum
dilut
pb
contain
tween
pbst
smp
pbst
incub
individu
strip
incub
tray
biorad
rock
hr
room
temperatur
strip
wash
pbst
min
room
temperatur
incub
dilut
hrpconjug
goat
antimous
igg
igm
dilut
hrpconjug
goat
antirabbit
igg
boehringermannheim
pbst
min
room
temperatur
strip
wash
develop
reaction
naphthol
biorad
substrat
hr
altern
substrat
dianisidin
dihydrochlorid
sigma
use
slightli
modifi
procedur
dergt
et
al
press
sampl
resuspend
sampl
buffer
laemmli
without
boil
min
store
analys
immedi
variou
percentag
polyacrylamid
gel
altern
sampl
resuspend
sampl
buffer
contain
urea
without
ph
sturman
incub
min
electrophoresi
fluorographi
perform
previous
describ
deregt
et
al
press
total
hybridoma
cell
line
monoclon
antibodi
chosen
detail
character
specif
protein
el
n
protein
respect
fig
antibodi
chosen
base
overal
superior
reactiv
assay
well
particular
interest
analyz
bcv
glycoprotein
monoclon
antibodi
igg
immunoglobulin
class
predomin
isotyp
igg
six
elisa
titer
ascit
fluid
rang
total
ascit
igg
determin
ra
analysi
done
polyacrylamid
gel
rang
lane
f
reactiv
detect
use
hrpconjug
rabbit
antimous
igg
igm
antibodi
substrat
use
dianisidin
dihydrochlorid
mw
posit
molecular
weight
standard
note
protein
probabl
aggreg
promin
analysi
usual
observ
mw
calcul
gel
use
thyroglobulin
mw
pharmacia
mw
standard
see
also
fig
dial
immunodiffus
rang
less
mgml
determin
monoclon
antibodi
could
neutral
viru
infect
vitro
without
aid
complement
heatinactiv
ascit
fluid
viru
mix
incub
plaqu
reduct
assay
tabl
monoclon
antibodi
protein
found
neutral
viru
infect
plaqu
reduct
titer
respect
none
monoclon
antibodi
el
n
protein
neutral
viru
infect
vitro
pattern
reactiv
monoclon
antibodi
monoclon
antibodi
protein
upon
initi
screen
radioimmunoprecipit
hybridoma
supernat
reactiv
observ
bind
design
precursor
well
higher
molecular
weight
speci
appar
aggreg
form
reactiv
sometim
difficult
assess
regularli
label
lysat
use
protein
often
occur
small
amount
fig
howev
pulsechas
experi
got
occur
quit
promin
prior
cleavag
go
deregf
et
al
press
thu
reciproc
highest
dilut
antibodi
ascit
fluid
gave
reduct
plaqu
number
fect
mockinfect
cell
respect
puls
min
chase
mem
min
immunoprecipit
repres
mab
protein
solubil
laemmli
sampl
buffer
without
analysi
polyacrylamid
gel
mw
posit
molecular
weight
standard
note
lane
repres
viru
undergon
two
freezethaw
cycl
solubil
portion
viru
use
previou
analysi
aggreg
appar
reflect
rel
promin
got
band
compar
previou
analysi
shown
appear
band
band
mw
approxim
use
molecular
weight
standard
presumpt
aggreg
trimer
gpl
assess
bind
select
monoclon
antibodi
relat
protein
lysat
prepar
methionin
pulsechas
cell
use
radioimmunoprecipit
monoclon
antibodi
immunoprecipit
appar
aggreg
fig
b
monoclon
antibodi
protein
differenti
reactiv
monoclon
antibodi
appar
degrad
fragment
gpl
upon
initi
character
radioimmunoprecipit
note
monoclon
antibodi
protein
react
differenti
mw
polypeptid
fig
lane
ac
polypeptid
found
glycosyl
data
shown
viru
specif
absenc
mockinfect
cell
lysat
fig
monoclon
antibodi
react
appar
higher
avid
gpl
monoclon
antibodi
mab
differenti
reactiv
c
hang
increas
decreas
amount
mab
use
exclus
sd
incub
mixtur
effect
immunoprecipit
possibl
immunoprecipit
supernat
incub
mixtur
mab
indic
differenti
reactiv
inde
due
bind
e
mab
lack
bind
polypeptid
e
mab
hc
data
shown
note
immunoprecipideregt
babiuk
tate
mab
purifi
viru
prepar
contain
reduc
polypeptid
approxim
mw
appear
fig
lane
polypeptid
also
glycosyl
data
shown
suspect
polypeptid
deriv
reduct
latter
protein
disulfidelink
dieter
similar
true
absent
reduc
condit
sinc
gpl
reduc
presenc
absenc
would
normal
difficult
assess
reduc
condit
due
lack
resolut
protein
howev
immunoprecipit
mab
demonstr
greater
reactiv
examin
assess
could
made
reduc
condit
absent
appar
replac
compar
fig
lane
f
f
indic
disulfidelink
dimer
probabl
ident
subunit
sinc
polypeptid
appar
role
genesi
observ
pulsechas
experi
deregt
et
al
press
conclud
degrad
product
design
ii
differenti
reactiv
monoclon
antibodi
differenti
reactiv
monoclon
antibodi
degrad
product
suggest
monoclon
antibodi
might
also
bind
differenti
precursor
monom
precursor
dimer
gpl
design
thu
determin
bind
abil
monoclon
antibodi
protein
bcvinfect
mockinfect
cell
puls
methionin
chase
mem
lysat
prepar
use
immunoprecipit
result
show
although
monoclon
antibodi
could
bind
gpl
fig
lane
c
e
g
mab
abl
immunoprecipit
monom
fig
lane
monoclon
antibodi
reveal
weak
bind
gpl
reaction
better
observ
puls
methionin
fig
lane
c
result
obtain
concentr
monoclon
antibodi
increas
decreas
sd
exclud
lysat
puls
cell
minor
amount
appar
mab
immunoprecipit
detect
along
appar
nonspecif
bind
nucleocapsid
protein
observ
lane
ad
gel
shown
fig
expos
time
longer
data
shown
could
distinguish
whether
due
weak
reaction
nonspecif
bind
slight
amount
reduct
immunoprecipit
sampl
prepar
nevertheless
consid
neg
result
base
differenti
reactiv
gpl
summar
tabl
monoclon
antibodi
defin
four
epitop
protein
determin
natur
bcv
epitop
bind
monoclon
antibodi
western
immunoblot
assay
studi
result
shown
fig
summar
tabl
monoclon
antibodi
protein
bound
sdsdenatur
antigen
western
immunoblot
fig
contrast
one
monoclon
antibodi
bound
antigen
denatur
sd
plu
although
weaker
reaction
antigen
denatur
sd
alon
observ
fig
also
bound
sdsdenatur
antigen
fig
howev
mab
hc
show
rel
weak
reaction
compar
mab
data
shown
none
monoclon
antibodi
could
react
antigen
denatur
sd
fig
thu
epitop
repres
panel
monoclon
antibodi
except
repres
mab
clone
design
sd
determin
studi
reactiv
antibodi
immunoblot
assay
plaqu
reduct
ascit
dilut
see
tabl
actual
titer
ntigen
boil
presenc
sd
sd
plu
prior
page
appar
depend
upon
disulfid
linkag
antigen
integr
rabbit
polyclon
antibcv
serum
also
show
appar
lack
reaction
reduc
speci
howev
weak
reaction
may
obscur
background
reaction
experi
fig
transfer
reduc
protein
confirm
methioninelabel
viru
immunoblot
data
shown
two
three
mab
specif
el
protein
mab
react
antigen
denatur
nonreduc
reduc
condit
fig
mab
n
specif
fig
el
monoclon
antibodi
also
react
appar
aggreg
el
notabl
speci
fig
distort
gel
front
reduc
protein
caus
e
protein
migrat
appar
lower
mobil
fig
extran
band
observ
appar
result
protein
degrad
aggreg
fig
particularli
lane
b
b
bind
characterist
monoclon
antibodi
use
competit
bind
assay
cba
bind
characterist
monoclon
antibodi
bcv
determin
parallel
elisa
titrat
use
singl
antigen
prepar
bind
curv
monoclon
antibodi
use
cba
construct
monoclon
antibodi
appar
deregt
babiuk
satur
bcv
dilut
data
shown
confirm
cba
typic
demonstr
maximum
level
competit
three
log
dilut
thu
amount
input
antibodi
repres
plateau
bind
curv
absorb
reach
plateau
reflect
amount
monoclon
antibodi
bound
bcv
use
approxim
measur
rel
avid
monoclon
antibodi
respect
protein
frankel
gerhard
stone
nowinski
bruck
et
howev
sinc
antiigg
antibodi
significantli
underrepres
hrpconjug
probe
determin
later
titrat
comparison
made
monoclon
antibodi
across
isotyp
limit
dilut
probe
result
suggest
mab
significantli
lower
rel
avid
protein
bind
measur
use
satur
near
satur
level
probe
similar
adsorb
reach
plateau
monoclon
antibodi
igg
igg
suggest
avid
similar
avid
monoclon
antibodi
igg
isotyp
appear
similar
assay
howev
sinc
protein
disulfidelink
dimer
appar
ident
subunit
variat
number
epitop
one
two
type
antibodi
bind
monoval
versu
bival
possibl
would
make
bind
comparison
meaningless
limit
dilut
probe
thu
bind
also
measur
satur
level
probe
similar
absorb
reach
plateau
monoclon
antibodi
indic
approxim
amount
antibodi
bind
occur
amount
input
antibodi
determin
topographi
epitop
glycoprotein
involv
neutral
monoclon
antibodi
describ
tabl
except
induc
insuffici
amount
ascit
ineffici
neutral
whose
epitop
could
distinguish
mean
conjug
hrp
use
probe
cba
conjug
appar
advers
effect
bind
properti
monoclon
antibodi
endpoint
titer
rang
approxim
bind
hrpconjug
monoclon
antibodi
inhibit
approxim
greater
monoclon
antibodi
except
presenc
satur
unlabel
homolog
antibodi
measur
avid
result
gener
agreement
deriv
bind
curv
result
typic
competit
bind
experi
shown
fig
summar
tabl
experi
monoclon
antibodi
anoth
bcv
protein
use
competitor
control
two
nonoverlap
antigen
region
defin
neutral
monoclon
antibodi
fig
monoclon
antibodi
demonstr
reciproc
competit
defin
one
region
design
fig
monoclon
antibodi
defin
second
region
design
b
fig
mab
antibodi
appar
low
avid
show
intermedi
level
competit
probe
howev
sinc
reciproc
competit
experi
could
done
lack
conjug
probe
monoclon
antibodi
assign
particular
antigen
group
note
summari
data
present
fig
percentag
competit
plateau
competit
bind
experi
delin
one
distinct
antigen
region
defin
monoclon
antibodi
anoth
design
c
respect
antigen
site
defin
overlap
two
region
design
b
sinc
data
present
report
indic
tab
bind
differ
epitop
antigen
region
defin
monoclon
antibodi
subdivid
design
epitop
specifi
respect
result
present
show
bcv
glycoprotein
induc
product
antibodi
effici
neutral
viru
infect
absenc
complement
previou
studi
shown
peplomer
protein
protein
respons
cell
membran
fusion
cellular
attach
major
neutral
antigen
coronavirus
antibodi
el
glycoprotein
littl
neutral
abil
absenc
complement
collin
et
vautherot
laport
talbot
et
al
wege
et
al
laud
al
jimenez
al
coronavirus
infecti
bronchiti
viru
transmiss
gastroenter
viru
tgev
beststudi
coronavirus
appar
lack
analog
protein
bcv
human
coronaviru
glycoprotein
sturman
holm
rottieret
al
cavanagh
stern
et
al
garw
pocock
hogu
et
al
hogu
brian
deregt
al
press
may
analog
protein
mhvjhm
howev
ident
protein
remain
unclear
wege
et
al
siddel
al
siddel
taguchi
al
sinc
protein
induc
effici
neutral
antibodi
suggest
protein
import
function
bovin
coronaviru
infect
howev
exact
natur
function
remain
determin
monoclon
antibodi
direct
defin
three
antigen
region
bcv
protein
two
region
induc
product
highli
effici
neutral
antibodi
antigen
integr
depend
upon
disulfid
linkag
least
six
major
antigen
site
protein
mhvjhm
identifi
competit
bind
assay
previou
studi
three
site
involv
neutral
viru
talbot
et
al
wege
al
four
major
antigen
site
found
tgev
protein
cba
two
site
respons
neutral
mediat
determin
six
neutral
epitop
could
distinguish
variou
criteria
anoth
studi
delma
al
jimenez
et
studi
employ
gener
larger
panel
monoclon
antibodi
protein
report
thu
whether
neutral
epitop
bcv
protein
site
could
identifi
larger
panel
monoclon
antibodi
use
remain
determin
wege
et
al
could
distinguish
three
class
monoclon
antibodi
pattern
immunoprecipit
protein
monoclon
antibodi
could
bind
three
protein
immunoprecipit
assay
high
neutral
titer
similarli
neutral
monoclon
antibodi
bcv
protein
report
immunoprecipit
analog
protein
gpl
three
antigen
domain
design
b
c
repres
four
distinct
epitop
could
defin
protein
present
panel
monoclon
antibodi
differenti
reactiv
monoclon
antibodi
gpl
radioimmunoprecipit
assay
ripa
distinguish
three
epitop
epitop
al
epitop
b
defin
mab
respect
epitop
c
defin
mab
respect
differenti
avid
mab
assay
consid
signific
suggest
appar
chang
epitop
conform
occur
proteolyt
cleav
one
allow
better
bind
condit
assay
assay
condit
like
import
mab
bind
sinc
although
bound
poorli
ripa
c
appear
bind
well
monoclon
antibodi
antibodi
bind
assay
two
pattern
reactiv
gpl
observ
monoclon
antibodi
pattern
distinguish
epitop
c
defin
mab
epitop
defin
mab
epitop
b
mab
bound
precursor
monom
epitop
c
defin
mab
exist
appar
complet
indic
exist
two
epitop
dimer
gpl
gpl
mab
bound
dimer
protein
indic
epitop
al
b
conform
depend
protein
dimer
howev
may
two
b
epitop
dimer
sinc
behavior
monoclon
antibodi
respect
similar
shown
mab
antibodi
bind
assay
result
obtain
western
immunoblot
suggest
epitop
al
b
defin
mab
hc
respect
might
partial
alter
sd
denatur
indic
weak
respons
assay
epitop
c
defin
respect
appar
fulli
resist
altern
may
indic
slight
avid
differ
monoclon
antibodi
epitop
howev
appar
destroy
sid
use
suggest
disulfid
linkag
essenti
antigen
occur
monom
reduc
condit
thu
loss
antigen
condit
would
expect
epitop
al
b
defin
monoclon
antibodi
bind
precursor
monom
radioimmunoprecipit
assay
convers
sinc
mab
epitop
c
bind
monom
might
expect
react
western
immunoblot
howev
sinc
monoclon
antibodi
react
sinc
intermolecular
disulfid
bond
appar
requir
epitop
antigen
indic
reactiv
mab
suggest
intramolecular
disulfid
bond
may
involv
preserv
epitop
conform
competit
bind
assay
indic
epitop
close
spatial
proxim
possibl
overlap
antigen
region
contain
epitop
al
overlap
b
b
c
result
present
indic
epitop
b
c
locat
remain
illdefin
appar
contain
least
one
intermolecular
disulfid
bond
bridg
monom
locat
epitop
specul
regard
although
appar
proxim
suggest
epitop
may
destroy
manner
upon
cleavag
import
antigen
region
protein
involv
neutral
appar
region
probabl
contain
close
adjac
biolog
import
domain
protein
yet
examin
whether
monoclon
antibodi
inhibit
bcv
hemagglutin
thu
whether
biolog
import
domain
domain
erythrocyt
bind
king
et
al
remain
determin
greater
interest
howev
determin
actual
function
protein
bovin
coronaviruscel
interact
studi
present
progress
